Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.

Journal of public health (Oxford, England)·2025
Same author

Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.

Journal of public health (Oxford, England)·2024
Same author

The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2016
Same author

Performance predictors of brain-computer interfaces in patients with amyotrophic lateral sclerosis.

Journal of neural engineering·2016
Same author

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

Neurology·2008
Same author

The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.

Neurology·2006

Related Experiment Video

Updated: Jun 27, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Chronic inflammatory demyelinating polyradiculoneuropathy.

Z Simmons

    Journal of Clinical Neuromuscular Disease
    |December 17, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune disorder requiring accurate diagnosis for effective treatment. This review provides guidelines for diagnosing and managing CIDP in adults and children, noting a generally good prognosis.

    More Related Videos

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
    04:55

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

    Published on: May 11, 2022

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
    08:56

    Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

    Published on: October 7, 2021

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
    04:55

    A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

    Published on: May 11, 2022

    Area of Science:

    • Neurology
    • Immunology

    Background:

    • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare immune-mediated neurological disorder.
    • Accurate diagnosis is crucial for effective management and relies on integrating clinical, electrodiagnostic, and laboratory findings.

    Purpose of the Study:

    • To review the pathogenesis, clinical presentation, evaluation, treatment, and prognosis of CIDP in adults and children.
    • To provide practical guidelines for selecting diagnostic tests and treatment modalities for CIDP.

    Main Methods:

    • Literature review of pathogenesis, clinical presentation, diagnosis, treatment, and prognosis of CIDP.
    • Synthesis of clinical, electrodiagnostic, and laboratory data for diagnostic accuracy.
    • Development of practical guidelines for diagnostic and therapeutic selection.

    Main Results:

    • CIDP is an immune-mediated disorder with a generally good prognosis.
    • Diagnosis requires a comprehensive approach combining various data types.
    • Appropriate treatment selection is key to successful outcomes.

    Conclusions:

    • Accurate and timely diagnosis of CIDP is essential for initiating appropriate treatment.
    • The review offers practical guidance for clinicians managing CIDP.
    • Early and effective management leads to a favorable prognosis for most patients.